Miastenia Grave
DOI:
https://doi.org/10.34024/rnc.2005.v13.8805Palavras-chave:
suplementoResumo
.
Referências
Carandina-Maffeis R, et al. Plasmapheresis in the treatment of myasthenia gravis: retrospective study of 26 patients. Arq Neuropsiquiatr 2004;62: 391-395. DOI: https://doi.org/10.1590/S0004-282X2004000300003
Dumitru D, Amato AA. Neuromuscular junction disorders. In: Dumitru D, Amato AA, Zwarts M (eds.). Electrodiagnostic medicine. 2ª ed. 2002, Filadelfia: Hanley & Belfus, 1127-1227.
Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000; 55: 7-15. DOI: https://doi.org/10.1212/WNL.55.1.7
Kesler KA, Wright CD, Loehrer PJ. Thymoma: current medical and surgical management. Semin Neurol 2004; 24:63-73. DOI: https://doi.org/10.1055/s-2004-829588
Phillips II LH. The epidemiology of myasthenia gravis. Semin Neurol 2004; 24: 17-20. DOI: https://doi.org/10.1055/s-2004-829593
Sieb JP. Myasthenia gravis: emerging new therapy options. Curr Opin Pharmacol 2005; 5:303-307. DOI: https://doi.org/10.1016/j.coph.2005.01.010
Vernino S, Cheshire WP, Lennon VA. Myasthenia grave with autoimmune autonomic neuropathy. Auton Neurosci 2001; 88: 187-192. DOI: https://doi.org/10.1016/S1566-0702(01)00239-9
Vincent A, et al. Seronegative myasthenia gravis. Semin Neurol 2004; 24:125-133. DOI: https://doi.org/10.1055/s-2004-829589
Yonger DS, Engel AG, Sanders DB. Advances in diagnosis, pathogenesis and treatment of myasthenia gravis. Neurology 1997; 48 (supll 5):S1-S80. DOI: https://doi.org/10.1212/WNL.48.Suppl_5.40S
